|1.||Nakamura, Hideji: 14 articles (01/2015 - 11/2002)|
|2.||Enomoto, Hirayuki: 11 articles (01/2015 - 11/2002)|
|3.||Tai, Ming-Hong: 10 articles (06/2015 - 09/2007)|
|4.||Yoshida, Kenya: 10 articles (02/2006 - 11/2002)|
|5.||Everett, Allen D: 8 articles (04/2010 - 12/2002)|
|6.||Uyama, Hirokazu: 8 articles (07/2007 - 11/2002)|
|7.||Hu, Tsung-Hui: 7 articles (06/2015 - 10/2003)|
|8.||Okuda, Yorihide: 7 articles (10/2006 - 11/2002)|
|9.||Kishima, Yoshihiko: 7 articles (06/2004 - 11/2002)|
|10.||Liu, Li-Feng: 6 articles (06/2015 - 10/2003)|
02/01/2009 - "This study investigated the expression and prognostic role of hepatoma-derived growth factor (HDGF) in colorectal stromal tumor. "
01/01/2005 - "Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF)."
09/01/2015 - "Hepatoma-derived growth factor (HDGF) has been reported to be a potential predictive and prognostic marker for several types of cancer and important in malignant biological behaviors. "
01/01/2015 - "Hepatoma-derived growth factor (HDGF) is a novel jack-of-all-trades in cancer. "
01/01/2015 - "Prognostic role of hepatoma-derived growth factor in solid tumors of Eastern Asia: a systematic review and meta- analysis."
|2.||Hepatocellular Carcinoma (Hepatoma)
01/01/2009 - "Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells."
11/01/2003 - "The present study investigated the expression of hepatoma-derived growth factor (HDGF) in human hepatocellular carcinoma (HCC) and in the liver during hepatocarcinogenesis in two rodent models. "
01/01/2015 - "Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma."
01/01/2013 - "Hepatoma-derived growth factor (HDGF) is a novel growth factor identified from human hepatoma cell line. "
12/01/2010 - "Hepatoma-derived growth factor (HDGF) was first purified as a growth factor secreted by hepatoma cells. "
|3.||Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/01/2011 - "Our previous studies revealed that hepatoma-derived growth factor (HDGF) is highly expressed in non-small cell lung cancer (NSCLC) cells, playing important roles in promoting NSCLC cells growth and invasion. "
08/20/2007 - "[Expression of hepatoma-derived growth factor and its clinical implication in stage I non-small cell lung cancer]."
01/01/2006 - "Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells."
06/01/2005 - "Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer."
08/15/2004 - "Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer."
|4.||Endometrial Neoplasms (Endometrial Cancer)
|5.||Neoplasm Metastasis (Metastasis)
10/06/2015 - "To clarify the role of hepatoma-derived growth factor (HDGF) and β-catenin in carcinogenesis of colorectal cancer (CRC), our results showed that high HDGF expression was found in CRC cells and tissues and significantly related to histological differentiation (p = 0.035) and lymph node metastasis (p = 0.000). "
08/24/2012 - "Hepatoma-derived growth factor (HDGF) stimulates the migration, invasion and metastasis in several types of cancer cells. "
01/01/2006 - "Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma."
01/01/2006 - "We recently reported that a high level of hepatoma-derived growth factor (HDGF) expression in tumors correlates with a high incidence of tumor relapse or distant metastasis and shortened survival time in patients with non-small cell lung cancer (NSCLC). "
06/01/2013 - "Downregulation of hepatoma-derived growth factor contributes to retarded lung metastasis via inhibition of epithelial-mesenchymal transition by systemic POMC gene delivery in melanoma."
|1.||Biological Markers (Surrogate Marker)
|2.||Conditioned Culture Media
|4.||human cationic antimicrobial protein CAP 37
|5.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|9.||Cellular Apoptosis Susceptibility Protein
|10.||Vitamin K 2 (Vitamin K2)